BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pharmaconomics//FDA Catalyst Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
BEGIN:VEVENT
UID:pharmaconomics-1423@pharmaconomics
DTSTAMP:20260707T040200Z
DTSTART;VALUE=DATE:20260608
DTEND;VALUE=DATE:20260609
SUMMARY:ALVO Catalyst — AVT16
DESCRIPTION:A key catalyst for AVT16 (proposed interchangeable biosimilar to Entyvio (vedolizumab) for intravenous administration) is expected Jun 8\, 2026.\n\nPrimary source: https://www.sec.gov/Archives/edgar/data/1898416/000117184326003974/f6k_060826.htm\n\nTrack it: https://pharmaconomics.com/e/1423
URL:https://pharmaconomics.com/e/1423
TRANSP:TRANSPARENT
BEGIN:VALARM
TRIGGER:-P1D
ACTION:DISPLAY
DESCRIPTION:ALVO catalyst tomorrow
END:VALARM
END:VEVENT
END:VCALENDAR